Clinical Trial Update: Post-approval Registry Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post-Implantation in Adolescent Idiopathic Scoliosis (AIS) [NA]

View source ↗

Summary

This is an ongoing post-approval registry study to monitor the long-term safety and probable benefit of the MID-C System for five years after implantation in ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adolescent Idiopathic Scoliosis

Drugs mentioned

• MID-C System

Snippet

Sponsor: Apifix | Conditions: Adolescent Idiopathic Scoliosis | NA | Status: ACTIVE_NOT_RECRUITING